Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation

por Hafner, Roderick Peter, Larché, Mark, Laidler, Paul, Hickey, Pascal, Hébert, Jacques
Publicado 2013

Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes

por Hafner, Roderick, Couroux, Peter, Armstrong, Kristen, Patel, Deepen, Larche, Mark, Haumann, Brett
Publicado 2013

Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study

por Hafner, Roderick Peter, Patel, Piyush, Salapatek, Annemarie, Laidler, Paul, Larché, Mark, Patel, Deepen
Publicado 2013

Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses

por Hafner, Roderick Peter, Couroux, Peter, Salapatek, Annemarie, Hickey, Pascal, Laidler, Paul, Larché, Mark, Patel, Deepen
Publicado 2013